Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
Conditions
- Advanced Malignant Neoplasm
- Cervical Squamous Cell Carcinoma
- Endometrial Carcinoma
- Malignant Uterine Neoplasm
- Recurrent Bladder Carcinoma
- Recurrent Breast Carcinoma
- Recurrent Cervical Carcinoma
- Recurrent Head and Neck Carcinoma
- Recurrent Malignant Neoplasm
- Recurrent Ovarian Carcinoma
- Recurrent Prostate Carcinoma
- Recurrent Renal Cell Carcinoma
- Solid Neoplasm
- Stage III Bladder Cancer
- Stage III Prostate Cancer
- Stage III Renal Cell Cancer
- Stage IIIA Breast Cancer
- Stage IIIA Cervical Cancer
- Stage IIIA Ovarian Cancer
- Stage IIIB Breast Cancer
- Stage IIIB Cervical Cancer
- Stage IIIB Ovarian Cancer
- Stage IIIC Breast Cancer
- Stage IIIC Ovarian Cancer
- Stage IV Breast Cancer
- Stage IV Ovarian Cancer
- Stage IV Prostate Cancer
- Stage IV Renal Cell Cancer
- Stage IVA Bladder Cancer
- Stage IVA Cervical Cancer
- Stage IVB Bladder Cancer
- Stage IVB Cervical Cancer
Interventions
- OTHER: Laboratory Biomarker Analysis
- DRUG: Nanoparticle Albumin-Bound Rapamycin
- OTHER: Quality-of-Life Assessment
Sponsor
Mayo Clinic
Collaborators